New paxlovid tablets tested for similarity in healthy volunteers
NCT ID NCT06397144
First seen Jan 08, 2026 · Last updated May 14, 2026 · Updated 17 times
Summary
This study was designed to check if new combination tablets of nirmatrelvir and ritonavir work the same as the already-approved Paxlovid tablets. Healthy adults would have received single doses of different tablet forms under fasting conditions, and blood samples would have been taken to measure drug levels. The study was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.